Citadel Advisors’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$132M Buy
3,087,924
+2,940,026
+1,988% +$118M 0.02% 644
2025
Q4
$5.54M Sell
147,898
-106,049
-42% -$3.56M ﹤0.01% 4135
2025
Q3
$7.51M Sell
253,947
-2,225,191
-90% -$51.7M ﹤0.01% 3674
2025
Q2
$58.5M Buy
2,479,138
+2,166,932
+694% +$45.2M 0.01% 1123
2025
Q1
$5.65M Sell
312,206
-109,046
-26% -$2.14M ﹤0.01% 3687
2024
Q4
$7.17M Buy
421,252
+100,018
+31% +$1.73M ﹤0.01% 3407
2024
Q3
$4.72M Sell
321,234
-894,173
-74% -$11.2M ﹤0.01% 4030
2024
Q2
$13.8M Sell
1,215,407
-1,777,547
-59% -$19.4M ﹤0.01% 2403
2024
Q1
$32.5M Buy
+2,992,954
New +$29.9M 0.01% 1580

Other funds holding BTSG

Citadel Advisors's BTSG Position: Q1 2026 in Review

Citadel Advisors increased its BrightSpring Health Services (BTSG) stake by 1,988% in Q1 2026, buying an estimated $118M and bringing the position to 3,087,924 shares worth $132M. The position accounts for 0.02% of the portfolio, ranked #644.

Citadel Advisors first reported a position in BTSG in Q1 2024 and has held it in 9 quarters since. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • Citadel Advisors held 3,087,924 shares of BrightSpring Health Services worth $132M as of Q1 2026.
  • Citadel Advisors bought 2,940,026 BrightSpring Health Services shares in Q1 2026, an estimated $118M.
  • BrightSpring Health Services made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #644 holding.
  • Citadel Advisors first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 9 quarters since.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.